Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapy
DOI:
https://doi.org/10.17532/jhsci.2021.1283Keywords:
Venous thromboembolism, homozygous Factor V Leiden mutation, anticoagulant therapyAbstract
Venous thromboembolism (VTE), also known as deep vein thrombosis and pulmonary thromboembolism, is a medical condition that has a high incidence and a multifactorial pathogenesis. One of the causes is a mutation of the Factor V Leiden (FVL), which is the most common inherited thrombotic disorder. A mutation inherited from both parents is found in about 0.05-0.5% of cases, making our case more medically interesting. We presented the case of a young male patient with recurrent VTE and few risk factors who was admitted to the hospital 4 times with VTE symptoms over a 5-year period. In the background, there was a homozygous FVL mutation and improper use of anticoagulant therapy. We examined the medical data, diagnostics, therapy, and precautions that were and are required.
Downloads
![](https://jhsci.ba/ojs/public/journals/1/submission_1283_870_coverImage_en_US.jpg)
Downloads
Published
License
Copyright (c) 2021 Sabira Šahinović, Vildana Huskić, Adis Kauković
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.